Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Staphylococcus saprophyticus From Clinical and Environmental Origins Have Distinct Biofilm Composition

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Rapid Open-Source SNP-Based Clustering Offers an Alternative to Core Genome MLST for Outbreak Tracing in a Hospital Setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Potential Advances of Adjunctive Hyperbaric Oxygen Therapy in Infective Endocarditis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Novel human in vitro vegetation simulation model for infective endocarditis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureus

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in patients with cystic fibrosis infection and with a compromised immune system. Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted. In recent years, numerous studies have demonstrated that antimicrobial peptides (AMPs) constitute potent agents against a range of pathogenic bacteria. However, AMPs possess a number of drawbacks such as susceptibility to proteolytic degradation with ensuing low bioavailability. To circumvent these undesired properties of AMPs unnatural amino acids or altered backbones have been incorporated to provide stable peptidomimetics with retained antibacterial activity. Here, we report on antimicrobial α-peptide/β-peptoid lysine-based peptidomimetics that exhibit high potency against clinical drug-resistant P. aeruginosa strains obtained from cystic fibrosis patients. These clinical strains possess phoQ and/or pmrB mutations that confer high resistance to colistin, the last-resort antibiotic for treatment of infections caused by P. aeruginosa. The lead peptidomimetic LBP-2 demonstrated a 12-fold improved anti-pseudomonal activity as compared to colistin sulfate as well as favorable killing kinetics, similar antibiofilm activity, and moderate cytotoxicity.

Original languageEnglish
JournalFrontiers in Microbiology
Pages (from-to)275
Publication statusPublished - 2019

ID: 59045832